Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Orthovita's Vitoss bone filler:

This article was originally published in Clinica

Executive Summary

Orthovita has received US FDA 510(k) clearance for its synthetic cancellous bone void filler for repairing bone defects in the spine, extremities and pelvis. The Vitoss scaffold, is made of a resorbable calcium phosphate, which has a porous, fine-particle structure that allows the product to become saturated with marrow, blood and nutrients required for bone growth and remodelling. The product will be launched in February, making it the Malvern, Pennsylvania company's first product on the US orthopaedic market. It is already available for sale in Europe.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069499

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel